Table 3.
Comparison of treatment-related characteristics between patients with CRE and those with CRAB
| Variable | Category | Total (n=418) | CRE (n=116) | CRAB (n=302) | p |
|---|---|---|---|---|---|
| Invasive procedures | Surgery | 215 (51.4) | 63 (54.3) | 152 (50.3) | 0.466 |
| Bronchoscopy | 94 (22.5) | 22 (19.0) | 72 (23.8) | 0.285 | |
| G-endoscopy | 63 (15.1) | 22 (19.0) | 41 (13.6) | 0.168 | |
| Invasive device | Urinary catheter | 380 (90.9) | 103 (88.8) | 277 (91.7) | 0.351 |
| Central catheter | 352 (84.2) | 93 (80.2) | 259 (85.8) | 0.161 | |
| Gastrointestinal tube | 336 (80.4) | 88 (75.9) | 248 (82.1) | 0.149 | |
| Arterial catheter | 322 (77.0) | 77 (66.4) | 245 (81.1) | 0.001 | |
| Mechanical ventilator | 275 (65.8) | 58 (50.0) | 217 (71.9) | <0.001 | |
| Drainage tube | 138 (33.0) | 42 (36.2) | 96 (31.8) | 0.390 | |
| Antibiotics | Penicillin | 274 (65.6) | 68 (58.6) | 206 (68.2) | 0.065 |
| Quinolone | 237 (56.7) | 59 (50.9) | 178 (58.9) | 0.136 | |
| Carbapenem | 228 (54.5) | 58 (50.0) | 170 (56.3) | 0.247 | |
| Cephalosporin | 225 (53.8) | 62 (53.4) | 163 (54.0) | 0.923 | |
| Vancomycin | 165 (39.5) | 43 (37.1) | 122 (40.4) | 0.533 | |
| Medication | Antiacids | 375 (89.7) | 103 (88.8) | 272 (90.1) | 0.701 |
| Steroids | 187 (44.7) | 46 (39.7) | 141 (46.7) | 0.195 | |
| TPN | 369 (88.3) | 90 (77.6) | 279 (92.4) | <0.001 |
Data are presented as n (%).
CRE, carbapenem-resistant Enterobacteriaceae; CRAB, carbapenem-resistant Acinetobacter baumannii; TPN, total parenteral nutrition.